Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
|Videos|May 25, 2017
Optimal Relationships Among Specialty Pharmacy Stakeholders
Author(s)Lauren Santye, Assistant Editor
Mark A. Vineis, vice president of specialty pharmacy at Cardinal Health, discusses how communication can be improved among manufacturers, pharmacy benefit managers, and specialty pharmacies.
Advertisement
Mark A. Vineis, vice president of specialty pharmacy at Cardinal Health, discusses how communication can be improved among manufacturers, pharmacy benefit managers, and specialty pharmacies.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Pharmacy Times
1
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
2
After 180 Years, Multiple Myeloma Gets a Definition of Cure
3
Influenza Vaccines Continue to Reduce Severe Disease and Death Across High-Risk Groups, Evidence Review Finds
4
New Data Reshape Nonstatin Lipid Therapy Choices
5